'Ideas to Innovation' is a podcast from Clarivate, a global leader in providing solutions to accelerate the lifecycle of innovation, helping customers solve some of the world's most complex problems. In Ideas to Innovation Season 2, you will hear inspiring stories told from a personal, on-the-ground perspective from the people who are most passionate about the positive outcomes they helped deliver. These are stories about innovation that, by the end of each episode, you can't help but think: "Wow, they really did that?" Clarivate. Accelerating innovation. https://clarivate.com/
Ideas to Innovation
Claim This Podcastby Clarivate
4.8(6 reviews)
47 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
'Ideas to Innovation' is a podcast from Clarivate, a global leader in providing solutions to accelerate the lifecycle of innovation, helping customers solve some of the world's most complex problems. In Ideas to Innovation Season 2, you will hear inspiring stories told from a personal, on-the-ground perspective from the people who are most passionate about the positive outcomes they helped deliver. These are stories about innovation that, by the end of each episode, you can't help but think: "Wow, they really did that?" Clarivate. Accelerating innovation. https://clarivate.com/
Language
🇺🇲
Publishing Since
5/11/2021
1 verified contact email on file for Ideas to Innovation
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 10, 2024
Your Window on the World of Innovation
<div class="OutlineElement Ltr SCXW126845184 BCX8"> <p class="Paragraph SCXW126845184 BCX8"><span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun" data-ccp-charstyle-defn= "{"ObjectId":"6acbb295-11d8-4dbd-abb4-cd39628a8c2c|8","ClassId":1073872969,"Properties":[201342446,"1",201342447,"5",201342448,"1",201342449,"1",469777841,"Calibri",469777842,"",469777843,"Calibri",469777844,"Calibri",201341986,"1",469769226,"Calibri",268442635,"22",469775450,"normaltextrun",201340122,"1",134233614,"true",469778129,"normaltextrun",335572020,"1",469778324,"Default Paragraph Font"]}"> In this concluding episode of</span></span> <a class= "Hyperlink SCXW126845184 BCX8" href= "https://clarivate.com/podcasts/ideas-to-innovation-season-three/" target="_blank" rel="noreferrer noopener"><span class= "TextRun Underlined SCXW126845184 BCX8" lang="EN-GB" xml:lang= "EN-GB" data-contrast="none"><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">Season 3 of "Ideas to Innovation</span></span></a><span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">," we reflect on our journey through the episodes published in 2024 that highlight the conversations</span> <span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">we’ve</span> <span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">enjoyed with some of the brightest minds in education,</span> <span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">healthcare</span> <span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">and intellectual property law.</span></span><span class="TextRun SCXW126845184 BCX8" lang= "EN-US" xml:lang="EN-US" data-contrast="auto"><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="eop" data-ccp-charstyle-defn= "{"ObjectId":"6acbb295-11d8-4dbd-abb4-cd39628a8c2c|9","ClassId":1073872969,"Properties":[201342446,"1",201342447,"5",201342448,"1",201342449,"1",469777841,"Calibri",469777842,"",469777843,"Calibri",469777844,"Calibri",201341986,"1",469769226,"Calibri",268442635,"22",469775450,"eop",201340122,"1",134233614,"true",469778129,"eop",335572020,"1",469778324,"Default Paragraph Font"]}"> </span></span><span class="EOP SCXW126845184 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW126845184 BCX8"> <p class="Paragraph SCXW126845184 BCX8"><span class= "EOP SCXW126845184 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW126845184 BCX8"> <p class="Paragraph SCXW126845184 BCX8"><span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">In</span></span> <a class= "Hyperlink SCXW126845184 BCX8" href= "https://clarivate.com/podcasts/ideas-to-innovation-season-three/reading-rights-americas-literacy-challenge/" target="_blank" rel="noreferrer noopener"><span class= "TextRun Underlined SCXW126845184 BCX8" lang="EN-GB" xml:lang= "EN-GB" data-contrast="none"><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">episode 6</span></span></a> <span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">in February, we explored America's literacy challenge with documentary filmmaker</span></span> <span class="TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">Jenny Mackenzie</span></span><span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">.</span> <span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">Jenny shared her personal connection to literacy and discussed the innovative strategies being used to promote reading rights across the United States. Her insights into reading</span> <span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">proficiency</span> <span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">and educational reform were both eye-opening and inspiring.</span></span><span class="TextRun SCXW126845184 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "eop"> </span></span><span class="EOP SCXW126845184 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW126845184 BCX8"> <p class="Paragraph SCXW126845184 BCX8"><span class= "EOP SCXW126845184 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW126845184 BCX8"> <p class="Paragraph SCXW126845184 BCX8"><span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">March brought us a conversation with</span></span> <span class="TextRun SCXW126845184 BCX8" lang= "EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">Renée Aguiar-</span><span class= "NormalTextRun SpellingErrorV2Themed SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">Lucander</span></span><span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">, CEO of</span> <span class= "NormalTextRun SpellingErrorV2Themed SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">Calliditas</span> <span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">Therapeutics, in</span></span> <a class= "Hyperlink SCXW126845184 BCX8" href= "https://clarivate.com/podcasts/ideas-to-innovation-season-three/pioneering-paths-the-tarpeyo-journey-to-fda-approval-and-beyond/" target="_blank" rel="noreferrer noopener"><span class= "TextRun Underlined SCXW126845184 BCX8" lang="EN-GB" xml:lang= "EN-GB" data-contrast="none"><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">episode 7</span></span></a><span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">, who detailed the groundbreaking journey of</span> <span class= "NormalTextRun SpellingErrorV2Themed SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">Tarpeyo</span><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">, a drug that promises to revolutionize the treatment of kidney disease. Renée explained the innovative path to FDA approval, setting new benchmarks in the pharmaceutical industry.</span></span><span class="TextRun SCXW126845184 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "eop"> </span></span><span class="EOP SCXW126845184 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW126845184 BCX8"> <p class="Paragraph SCXW126845184 BCX8"><span class= "EOP SCXW126845184 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW126845184 BCX8"> <p class="Paragraph SCXW126845184 BCX8"><span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">We delved into the impact of artificial intelligence on intellectual property law in</span></span> <a class="Hyperlink SCXW126845184 BCX8" href= "https://clarivate.com/podcasts/ideas-to-innovation-season-three/navigating-the-ai-frontier-in-intellectual-property-law/" target="_blank" rel="noreferrer noopener"><span class= "TextRun Underlined SCXW126845184 BCX8" lang="EN-GB" xml:lang= "EN-GB" data-contrast="none"><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">episode 8</span></span></a> <span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">in April, with</span></span> <span class="TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang= "EN-GB" data-contrast="auto"><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">Jay Myers</span></span> <span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">from Seyfarth Shaw and</span></span> <span class="TextRun SCXW126845184 BCX8" lang= "EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">Arun Hill</span></span> <span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">from Clarivate. They</span> <span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">provided</span> <span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">valuable insights into how AI is transforming trademark searches, infringement monitoring and strategic brand decisions while addressing the ethical challenges that come with these advancements.</span></span><span class= "TextRun SCXW126845184 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="eop"> </span></span><span class= "EOP SCXW126845184 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW126845184 BCX8"> <p class="Paragraph SCXW126845184 BCX8"><span class= "EOP SCXW126845184 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW126845184 BCX8"> <p class="Paragraph SCXW126845184 BCX8"><span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">As we wrap up Season 3, we hope the episodes have informed, inspired, and entertained you.</span> <span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">You can</span> <span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">also listen to the Season 3 episodes</span> <span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">from</span> <span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">2023 – our</span></span> <a class= "Hyperlink SCXW126845184 BCX8" href= "https://clarivate.com/podcasts/ideas-to-innovation-season-three/innovating-tomorrow-unveiling-2023s-triumphs-from-ideas-to-reality/" target="_blank" rel="noreferrer noopener"><span class= "TextRun Underlined SCXW126845184 BCX8" lang="EN-GB" xml:lang= "EN-GB" data-contrast="none"><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">end-of-year episode</span></span></a> <span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">summarizes the five stories we shared between September</span> <span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">and</span> <span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">December.</span><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun"> </span></span><span class= "TextRun SCXW126845184 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="eop"> </span></span><span class= "EOP SCXW126845184 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW126845184 BCX8"> <p class="Paragraph SCXW126845184 BCX8"><span class= "EOP SCXW126845184 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW126845184 BCX8"> <p class="Paragraph SCXW126845184 BCX8"><span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">"Ideas to Innovation" will return later this year with more stories that</span> <span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">showcase</span> <span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">the power of human intellect and innovation.</span></span><span class="TextRun SCXW126845184 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "eop"> </span></span><span class="EOP SCXW126845184 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW126845184 BCX8"> <p class="Paragraph SCXW126845184 BCX8"><span class= "EOP SCXW126845184 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW126845184 BCX8"> <p class="Paragraph SCXW126845184 BCX8"><span class= "TextRun SCXW126845184 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">Stay</span> <span class= "NormalTextRun ContextualSpellingAndGrammarErrorV2Themed SCXW126845184 BCX8" data-ccp-charstyle="normaltextrun">curious, and</span> <span class= "NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle= "normaltextrun">thank you for listening.</span></span><span class= "TextRun SCXW126845184 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW126845184 BCX8" data-ccp-charstyle="eop"> </span></span><span class= "EOP SCXW126845184 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div>
April 16, 2024
Navigating the AI Frontier in Intellectual Property Law
<div class="OutlineElement Ltr SCXW176640376 BCX8"> <p class="Paragraph SCXW176640376 BCX8"><span class= "TextRun SCXW176640376 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="normaltextrun" data-ccp-charstyle-defn= "{"ObjectId":"2cdc0d8c-4428-4cf7-9aa3-d2548d85602d|8","ClassId":1073872969,"Properties":[469775450,"normaltextrun",201340122,"1",134233614,"true",469778129,"normaltextrun",335572020,"1",469778324,"Default Paragraph Font"]}"> In this episode of Ideas to Innovation, we delve into the transformative influence of artificial intelligence (AI) on intellectual property (IP) and trademark law. Our conversation with guests </span></span><a class="Hyperlink SCXW176640376 BCX8" href="https://www.linkedin.com/in/jay-myers-6a36b26/" target= "_blank" rel="noreferrer noopener"><span class= "TextRun Underlined SCXW176640376 BCX8" lang="EN-GB" xml:lang= "EN-GB" data-contrast="none"><span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "normaltextrun">Jay Myers</span></span></a><span class= "TextRun SCXW176640376 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="normaltextrun">, Director of Innovation for the Intellectual Property Practice Group at the Seyfarth Shaw international law firm, and</span></span> <a class= "Hyperlink SCXW176640376 BCX8" href= "https://www.linkedin.com/in/arunchill-consulltant/" target= "_blank" rel="noreferrer noopener"><span class= "TextRun Underlined SCXW176640376 BCX8" lang="EN-GB" xml:lang= "EN-GB" data-contrast="none"><span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "normaltextrun">Arun Hill</span></span></a><span class= "TextRun SCXW176640376 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="normaltextrun">, Senior Consultant, The Clarivate Center for</span> <span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "normaltextrun">IP</span> <span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "normaltextrun">and Innovation Research, unravels the complexities of integrating AI into legal practices.</span></span><span class= "TextRun SCXW176640376 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="eop" data-ccp-charstyle-defn= "{"ObjectId":"2cdc0d8c-4428-4cf7-9aa3-d2548d85602d|9","ClassId":1073872969,"Properties":[469775450,"eop",201340122,"1",134233614,"true",469778129,"eop",335572020,"1",469778324,"Default Paragraph Font"]}"> </span></span><span class="EOP SCXW176640376 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW176640376 BCX8"> <p class="Paragraph SCXW176640376 BCX8"><span class= "TextRun SCXW176640376 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="normaltextrun">Our discussion illuminates AI's</span> <span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="normaltextrun">capacity</span> <span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "normaltextrun">to streamline trademark searches, enhance infringement monitoring, and inform strategic brand decisions. Yet, it also confronts the ethical dilemmas and practical challenges that</span> <span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="normaltextrun">accompany</span> <span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "normaltextrun">AI's rise in the legal domain. </span></span><span class="TextRun SCXW176640376 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "eop"> </span></span><span class="EOP SCXW176640376 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW176640376 BCX8"> <p class="Paragraph SCXW176640376 BCX8"><span class= "TextRun SCXW176640376 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="normaltextrun">As we peer into the near future, our guests</span> <span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="normaltextrun">speculate</span> <span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "normaltextrun">on an era marked by increased efficiency and higher-quality decision-making in IP law, driven by AI's augmentation of human</span> <span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "normaltextrun">expertise</span><span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "normaltextrun">. This vision underscores the importance of balancing technological advancements with the indispensable elements of human judgment and ethical considerations.</span></span><span class= "TextRun SCXW176640376 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="eop"> </span></span><span class= "EOP SCXW176640376 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW176640376 BCX8"> <p class="Paragraph SCXW176640376 BCX8"><span class= "TextRun SCXW176640376 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="normaltextrun">This episode offers invaluable insights into how organizations can</span> <span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "normaltextrun">leverage</span> <span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "normaltextrun">AI to navigate the complexities of IP law, striking a balance between innovation and the critical human element of legal</span> <span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="normaltextrun">expertise</span><span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "normaltextrun">.</span></span><span class= "TextRun SCXW176640376 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="eop"> </span></span><span class= "EOP SCXW176640376 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div> <div class="OutlineElement Ltr SCXW176640376 BCX8"> <p class="Paragraph SCXW176640376 BCX8"><span class= "TextRun SCXW176640376 BCX8" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class="NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle="normaltextrun">Join us to explore how AI is not only automating tasks but also augmenting the capabilities of IP professionals to achieve higher-quality outcomes for their clients.</span></span><span class="TextRun SCXW176640376 BCX8" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class= "NormalTextRun SCXW176640376 BCX8" data-ccp-charstyle= "eop"> </span></span><span class="EOP SCXW176640376 BCX8" data-ccp-props= "{"134233117":false,"134233118":false,"201341983":0,"335559738":0,"335559739":0,"335559740":240}"> </span></p> </div>
March 7, 2024
Pioneering Paths: The Tarpeyo Journey to FDA Approval and Beyond
<p class="paragraph" style= "margin: 0in; vertical-align: baseline;"><span class= "normaltextrun"><span lang="EN-GB" style= "font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI'; mso-ansi-language: EN-GB;" xml:lang="EN-GB">The remarkable journey of</span></span> <a href= "https://www.calliditas.se/" target="_blank" rel= "noopener"><span class="normaltextrun"><span lang="EN-GB" style= "font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI'; color: #0563c1; mso-ansi-language: EN-GB;" xml:lang="EN-GB">Calliditas Therapeutics</span></span></a> <span class="normaltextrun"><span lang="EN-GB" style= "font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI'; mso-ansi-language: EN-GB;" xml:lang="EN-GB">and its groundbreaking drug, Tarpeyo, sheds light on the company’s innovative strategies and relentless pursuit of excellence that led to the successful approval of Tarpeyo by the U.S. Food and Drug Administration (FDA) for the treatment of a specific kidney disease. Our guest in this episode,</span></span> <a href= "https://www.linkedin.com/in/renee-aguiar-lucander-63373418/" target="_blank" rel="noopener"><span class= "normaltextrun"><span lang="EN-GB" style= "font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI'; color: #0563c1; mso-ansi-language: EN-GB;" xml:lang="EN-GB">Renée Aguiar-Lucander</span></span></a><span class="normaltextrun"><span lang="EN-GB" style= "font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI'; mso-ansi-language: EN-GB;" xml:lang="EN-GB">, CEO of Calliditas Therapeutics, reveals how their pioneering approach to drug development has set a new benchmark in the pharmaceutical industry.</span></span><span class= "eop"><span style= "font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI';"> </span></span></p> <p><span class="normaltextrun"><span lang="EN-GB" style= "font-size: 11.0pt; line-height: 107%; font-family: 'Avenir Next LT Pro',sans-serif; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: 'Segoe UI'; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;" xml:lang="EN-GB">We explore how Calliditas Therapeutics' groundbreaking work in securing FDA approval not only marks a significant milestone for the company but also inspires a new wave of innovation in</span></span> <span class= "normaltextrun"><span lang="EN-GB" style= "font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI'; mso-ansi-language: EN-GB;" xml:lang="EN-GB">the treatment of kidney diseases. Discover the power of pioneering drug development and the bright future it heralds for patients worldwide.</span></span><span class= "eop"><span style= "font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI';"> </span></span></p> <p class="paragraph" style= "margin: 0in; vertical-align: baseline;"><span class= "normaltextrun"><span lang="EN-GB" style= "font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI'; mso-ansi-language: EN-GB;" xml:lang="EN-GB">This episode also features insights from</span></span> <a href= "https://www.linkedin.com/in/mike-ward-755b677/" target="_blank" rel="noopener"><span class="normaltextrun"><span lang="EN-GB" style="font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI'; color: #0563c1; mso-ansi-language: EN-GB;" xml:lang="EN-GB">Mike Ward</span></span></a><span class= "normaltextrun"><span lang="EN-GB" style= "font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI'; mso-ansi-language: EN-GB;" xml:lang="EN-GB">, Global Head of Life Sciences and Healthcare Thought Leadership at Clarivate, highlighting the importance of the</span></span> <a href="https://clarivate.com/drugs-to-watch/" target="_blank" rel="noopener"><span class= "normaltextrun"><span lang="EN-GB" style= "font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI'; color: #0563c1; mso-ansi-language: EN-GB;" xml:lang="EN-GB">Drugs to Watch 2024 report</span></span></a> <span class="normaltextrun"><span lang="EN-GB" style= "font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI'; mso-ansi-language: EN-GB;" xml:lang="EN-GB">and the potential of Tarpeyo – one of 13 drugs to watch included in the report – to significantly improve patient outcomes.</span></span><span class="eop"><span style= "font-size: 11.0pt; font-family: 'Avenir Next LT Pro',sans-serif; mso-bidi-font-family: 'Segoe UI';"> </span></span></p> <p><span class="normaltextrun"><span lang="EN-GB" style= "font-size: 11.0pt; line-height: 107%; font-family: 'Avenir Next LT Pro',sans-serif; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: 'Segoe UI'; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;" xml:lang="EN-GB">Discover a story of resilience, innovation, and success behind Tarpeyo's journey to the American market, and the broader implications for the pharmaceutical industry's approach to drug development and regulatory approval.<span class= "eop"><span style= "font-size: 11.0pt; line-height: 107%; font-family: 'Avenir Next LT Pro',sans-serif; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: 'Segoe UI'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"> </span></span></span></span></p>
47 total episodes available
Deep-dive analytics for Ideas to Innovation
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Ideas to Innovation?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.